Cargando…
Oxaliplatin-related neuropathy in Indian patients – no difference between generic and original molecules
BACKGROUND: Oxaliplatin-induced neuropathy is a dose-limiting toxicity that significantly affects patients’ quality of life. The aim of this study was to compare its occurrence between a generic versus the original molecule in Indian patients. MATERIALS AND METHODS: Between August 2012 and July 2013...
Autores principales: | Sirohi, Bhawna, Ostwal, Vikas, Dawood, Shaheenah, Lopes, Gilberto, Talole, Sanjay, Nashikkar, Chaitali, Shrikhande, Shailesh |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Medknow Publications & Media Pvt Ltd
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5234165/ https://www.ncbi.nlm.nih.gov/pubmed/28144095 http://dx.doi.org/10.4103/0971-5851.195745 |
Ejemplares similares
-
Perioperative Epirubicin, Oxaliplatin, and Capecitabine Chemotherapy in Locally Advanced Gastric Cancer: Safety and Feasibility in an Interim Survival Analysis
por: Ostwal, Vikas, et al.
Publicado: (2017) -
Clinical practice and outcomes in advanced gastrointestinal stromal tumor: Experience from an Indian tertiary care center
por: Bose, Subhadeep, et al.
Publicado: (2017) -
Cystic lesions of the pancreas: Improved understanding, diagnostics and refined outcomes
por: Sirohi, Bhawna, et al.
Publicado: (2013) -
Down-staging following neoadjuvant chemo-radiotherapy for locally advanced rectal cancer: Does timing of surgery really matter?
por: Sirohi, Bhawna, et al.
Publicado: (2014) -
Clinical trials in India: At uncertain crossroads?
por: Sirohi, Bhawna, et al.
Publicado: (2014)